Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

Lofland, J; Kim, S; Batenhorst, A; Johnson, N; Chatterton, M; Cady, R; Kaniecki, R; Nash, D

Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

https://hdl.handle.net/10536/DRO/DU:30066518
Open external identifier URL

journal contribution

posted on 2024-06-13, 08:51 authored by J Lofland, S Kim, A Batenhorst, N Johnson, M Chatterton, R Cady, R Kaniecki, D Nash

Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

History

Location

New York, N. Y.

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2001, Elsevier

Journal

Mayo Clinic proceedings

Volume

76

Pagination

1093-1101

ISSN

0025-6196

eISSN

1942-5546

Issue

11

Publisher

Elsevier

Publication URL

http://search.proquest.com/docview/216875570/537A96FC7B794891PQ/7?accountid=10445

Usage metrics

Keywords

sumatriptan therapy acute migraine cost-effectiveness cost-benefit 119999 Medical and Health Sciences not elsewhere classified 970111 Expanding Knowledge in the Medical and Health Sciences

Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine

History

Location

Language

Publication classification

Copyright notice

Journal

Volume

Pagination

ISSN

eISSN

Issue

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports